New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.

Isaacs, W B; Isaacs, J T; Kyprianou, N; Burgers, J K; Alexander, R B; Partin, A W; Mohler, J L; Marshall, F F; Coffey, D S

Isaacs, W B; Isaacs, J T; Kyprianou, N; Burgers, J K; Alexander, R B; Partin, A W; Mohler, J L; Marshall, F F; Coffey, D S.

Affiliation

Isaacs WB; Johns Hopkins Oncology Center, Johns Hopkins School of Medicine, Baltimore, Md.

Eur Urol ; 18 Suppl 2: 33-5, 1990.

Article in En | MEDLINE | ID: mdl-2226604

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Renal Cell/drug therapy; Carcinoma, Renal Cell/secondary; Kidney Neoplasms/drug therapy; Animals; Cell Movement/physiology; Etoposide/administration & dosage; Humans; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Combined Chemotherapy Protocols / Kidney Neoplasms Limits: Animals / Humans Language: En Journal: Eur Urol Year: 1990 Document type: Article Affiliation country: Moldova Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links